Literature DB >> 32450774

A call to research: the relationship between SARS-2-CoV, ACE 2 and antihypertensives.

Antonio Cassone1, Donatella Gucciardo2, Roberto Cauda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32450774      PMCID： PMC7448903          DOI： 10.1080/20477724.2020.1765650

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


× No keyword cloud information.
  10 in total

1.  [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].

Authors:  M L Sun; J M Yang; Y P Sun; G H Su
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2020-02-16

2.  Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.

Authors:  Yuichiro Ishiyama; Patricia E Gallagher; David B Averill; E Ann Tallant; K Bridget Brosnihan; Carlos M Ferrario
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

3.  A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.

Authors:  Akram Khan; Cody Benthin; Brian Zeno; Timothy E Albertson; John Boyd; Jason D Christie; Richard Hall; Germain Poirier; Juan J Ronco; Mark Tidswell; Kelly Hardes; William M Powley; Tracey J Wright; Sarah K Siederer; David A Fairman; David A Lipson; Andrew I Bayliffe; Aili L Lazaar
Journal:  Crit Care       Date:  2017-09-07       Impact factor: 9.097

4.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations.

Authors:  Yanan Cao; Lin Li; Zhimin Feng; Shengqing Wan; Peide Huang; Xiaohui Sun; Fang Wen; Xuanlin Huang; Guang Ning; Weiqing Wang
Journal:  Cell Discov       Date:  2020-02-24       Impact factor: 10.849

5.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

6.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.

Authors:  Yuanyuan Zhang; Yaning Li; Renhong Yan; Lu Xia; Yingying Guo; Qiang Zhou
Journal:  Science       Date:  2020-03-04       Impact factor: 47.728

7.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Authors:  Keiji Kuba; Yumiko Imai; Shuan Rao; Hong Gao; Feng Guo; Bin Guan; Yi Huan; Peng Yang; Yanli Zhang; Wei Deng; Linlin Bao; Binlin Zhang; Guang Liu; Zhong Wang; Mark Chappell; Yanxin Liu; Dexian Zheng; Andreas Leibbrandt; Teiji Wada; Arthur S Slutsky; Depei Liu; Chuan Qin; Chengyu Jiang; Josef M Penninger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440

8.  Angiotensin-converting enzyme 2 protects from severe acute lung failure.

Authors:  Yumiko Imai; Keiji Kuba; Shuan Rao; Yi Huan; Feng Guo; Bin Guan; Peng Yang; Renu Sarao; Teiji Wada; Howard Leong-Poi; Michael A Crackower; Akiyoshi Fukamizu; Chi-Chung Hui; Lutz Hein; Stefan Uhlig; Arthur S Slutsky; Chengyu Jiang; Josef M Penninger
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

Review 9.  COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Authors:  Piercarlo Sarzi-Puttini; Valeria Giorgi; Silvia Sirotti; Daniela Marotto; Sandro Ardizzone; Giuliano Rizzardini; Spinello Antinori; Massimo Galli
Journal:  Clin Exp Rheumatol       Date:  2020-03-22       Impact factor: 4.473

10.  Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.

Authors:  David Gurwitz
Journal:  Drug Dev Res       Date:  2020-03-04       Impact factor: 5.004
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.